共 32 条
- [32] RETRACTION: An interim analysis of real-world safety data from an ongoing, non-interventional, observational study of patients with inflammatory bowel disease treated with CT-P13, an infliximab biosimilar, in the context of usual care with reference infliximab (Retraction of Vol 13, Pg S 410, 2019) JOURNAL OF CROHNS & COLITIS, 2020, 14 (03) : 428 - 428